These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38097863)

  • 21. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
    Knudsen AB; Trentham-Dietz A; Kim JJ; Mandelblatt JS; Meza R; Zauber AG; Castle PE; Feuer EJ
    JAMA Netw Open; 2023 Nov; 6(11):e2344698. PubMed ID: 37991759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective interventions to facilitate the uptake of breast, cervical and colorectal cancer screening: an implementation guideline.
    Brouwers MC; De Vito C; Bahirathan L; Carol A; Carroll JC; Cotterchio M; Dobbins M; Lent B; Levitt C; Lewis N; McGregor SE; Paszat L; Rand C; Wathen N
    Implement Sci; 2011 Sep; 6():112. PubMed ID: 21958602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.
    Haas JS; Sprague BL; Klabunde CN; Tosteson AN; Chen JS; Bitton A; Beaber EF; Onega T; Kim JJ; MacLean CD; Harris K; Yamartino P; Howe K; Pearson L; Feldman S; Brawarsky P; Schapira MM;
    J Gen Intern Med; 2016 Jan; 31(1):52-9. PubMed ID: 26129780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the role of access in Hispanic cancer screening disparities.
    Spencer JC; Noel L; Shokar NK; Pignone MP
    Cancer; 2023 May; 129(10):1569-1578. PubMed ID: 36787126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
    Mondragón Márquez LI; Domínguez Bueso DL; González Ruiz LM; Liu JJ
    Cancer Causes Control; 2023 Dec; 34(12):1073-1084. PubMed ID: 37486400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
    Alba C; Zheng Z; Wadhera RK
    JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening.
    Liu BY; O'Malley J; Mori M; Fagnan LJ; Lieberman D; Morris CD; Buckley DI; Heintzman JD; Carney PA
    J Am Board Fam Med; 2014; 27(5):669-81. PubMed ID: 25201936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the social vulnerability index and breast, cervical, and colorectal cancer screening rates in Rhode Island.
    Hwang J; Risica PM; Lamy E; Goedel W
    Cancer Causes Control; 2024 Aug; 35(8):1143-1149. PubMed ID: 38613745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    Mohan G; Chattopadhyay S
    JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States.
    Shete S; Deng Y; Shannon J; Faseru B; Middleton D; Iachan R; Bernardo B; Balkrishnan R; Kim SJ; Huang B; Millar MM; Fuemmler B; Jensen JD; Mendoza JA; Hu J; Lazovich D; Robertson L; Demark-Wahnefried W; Paskett ED;
    JAMA Netw Open; 2021 Oct; 4(10):e2128000. PubMed ID: 34605915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low health literacy and cancer screening among Chinese Americans in California: a cross-sectional analysis.
    Sentell TL; Tsoh JY; Davis T; Davis J; Braun KL
    BMJ Open; 2015 Jan; 5(1):e006104. PubMed ID: 25564140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
    Menvielle G; Dugas J; Richard JB; Luce D
    Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 36. Patterns and Trends of Cancer Screening in Canada: Results From a Contemporary National Survey.
    Abdel-Rahman O
    J Natl Compr Canc Netw; 2021 Jan; 19(1):68-76. PubMed ID: 33406489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 38. Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
    Quintal C; Antunes M
    Acta Med Port; 2023 Sep; 36(9):577-587. PubMed ID: 37339163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diffusion of screening programmes in Italy, year 2009.
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.